Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
about
Cdx-2 expression in squamous and metaplastic columnar epithelia of the esophagus.Multilayered epithelium in a rat model and human Barrett's esophagus: similar expression patterns of transcription factors and differentiation markers.Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagusEctopic Cdx2 expression in murine esophagus models an intermediate stage in the emergence of Barrett's esophagus.Esophageal adenocarcinoma: treatment modalities in the era of targeted therapy.Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus.Modeling human gastrointestinal inflammatory diseases using microphysiological culture systems.Biology of Barrett's esophagus and esophageal adenocarcinomaCDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.CDX2 as a marker for intestinal differentiation: Its utility and limitations.Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in KoreaRelationships of CDXs and apical sodium-dependent bile acid transporter in Barrett's esophagus.Evolution of oesophageal adenocarcinoma from metaplastic columnar epithelium without goblet cells in Barrett's oesophagusAcid, bile, and CDX: the ABCs of making Barrett's metaplasia.Absence of Na+/sugar cotransport activity in Barrett's metaplasiaSingle nucleotide polymorphisms of caudal type homeobox 1 and 2 are associated with Barrett's esophagus.Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia.Molecular mechanisms of Barrett's esophagus.Molecular biomarkers and ablative therapies for Barrett's esophagus.The changing role of the pathologist in the management of Barrett's oesophagus.Current issues in Barrett's esophagus and Barrett's-related dysplasia.Transcommitment: Paving the Way to Barrett's Metaplasia.The Barrett's Gland in Phenotype Space.Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.CDX2 hox gene product in a rat model of esophageal cancerSox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.Pathogenesis of Barrett's esophagus: bile acids inhibit the Notch signaling pathway with induction of CDX2 gene expression in human esophageal cells.Dynamics of SOX2 and CDX2 Expression in Barrett's Mucosa.Transgenic overexpression of cdx1b induces metaplastic changes of gene expression in zebrafish esophageal squamous epithelium.Intestinal metaplasia in Barrett's oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett's tumour.Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus.Mid-Esophagus Columnar Metaplasia: What Is the Biopathogenic Pathway?Definition, Derivation, and Diagnosis of Barrett's Esophagus: Pathological Perspectives.Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?Foveolar type dysplasia in Barrett esophagusPediatric Columnar Lined Esophagus vs Barrett's Esophagus: Is it the Time for a Consensus Definition?
P2860
Q33251710-33FA6151-D380-48AC-B8C6-9311753330A9Q33314440-508C69C4-6B97-4008-BF8B-E2C968434FF8Q33596309-479698F6-B628-41CE-BE22-6698B05A0208Q33873724-A5E57854-6CCB-4FB8-A5BE-0F75BFB4B817Q33932460-CA2763DD-74FB-4F62-BDD8-90D614501707Q33987356-85C404E4-11C6-4295-B8FD-DA3ADB9D5102Q34143148-40D70913-C774-41AB-A6A1-9344EDDEABC5Q34644324-12A3EF42-3F26-441E-8A9B-162B92546475Q35152381-70E525BD-E88A-44ED-BF96-8A916EDC65E3Q35618815-5665B412-6779-4589-8652-EB1A674A68F1Q36817410-C88860A5-44DB-43E0-8253-A8EE34CC9A48Q36841300-AA20D3D6-08E9-4AAF-9B4E-5DE357EC5499Q36968814-C1E2CF5E-EA33-40DE-9A6D-4BD7A608743CQ37192028-02B9F5B6-798A-42FC-BC61-97DFC66C4210Q37220658-2D637C54-B9ED-42C2-A1D0-CF5ED5AB2110Q37625982-F3B35F03-D1B3-455E-B9A3-077F9F631C50Q37809363-18ADCABF-BB94-4AFC-A9B6-0E6D34227740Q37943774-6C1DCC06-5DA7-445A-8D61-B6458F943DE5Q38051702-61A8BE17-8968-48EA-A515-97994CE71948Q38210245-FBCF6F5A-B2FD-416B-A7CC-CE96370C1682Q38308045-1CFCCD31-9309-452C-929E-1A75A473E590Q38940526-BF79B39E-76BE-4831-9EBA-307A4EDA22D8Q39100481-F8F3655F-AD2A-4AB9-97F3-19D20DF4FFAEQ39268802-15766A88-1926-4782-BA36-EE1B8B4023B6Q39433403-6DA9ADA7-5379-4F90-88C7-6426448DFD77Q39536731-F6831CBB-7891-4770-B967-D14AD3D3F708Q39793635-B469602A-8824-42D4-8E35-B778ED72C845Q41430355-06431F8C-ABFD-4918-8CE7-1A947B444689Q41580778-BBBDDD41-C26B-4AD4-B46C-4E04FF4F88CFQ43684809-E69C58C6-9BF3-4EDA-8975-FF892330A054Q48233200-97166745-929D-490C-B859-8F8931388368Q53015033-4D99C8B7-FFCE-434B-BAF3-DB9A7D6DD4D1Q53038475-FF7B1AD0-5395-4125-83EF-E257FC6A5550Q57260006-4EE6EF4C-580C-41FB-B156-AC70D5819BE7Q57742753-6AD1500B-7EFE-414E-8373-BF6059F2C346Q57828329-E1DAE38F-4FBB-43EE-8732-CCA105BC8276
P2860
Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Expression of the intestinal m ...... stinal (Barrett's) metaplasia.
@en
Expression of the intestinal m ...... us with and without intestinal
@nl
type
label
Expression of the intestinal m ...... stinal (Barrett's) metaplasia.
@en
Expression of the intestinal m ...... us with and without intestinal
@nl
prefLabel
Expression of the intestinal m ...... stinal (Barrett's) metaplasia.
@en
Expression of the intestinal m ...... us with and without intestinal
@nl
P2093
P2860
P1433
P1476
Expression of the intestinal m ...... stinal (Barrett's) metaplasia.
@en
P2093
Alona Meir
Gabriel M Groisman
P2860
P2888
P304
P356
10.1038/MODPATHOL.3800182
P577
2004-10-01T00:00:00Z